Skip to content
Our Company
Pipeline
Science
Investors
Careers
Contact
Retreatment with BarzolvolimabLeads to Rapid Improvement in Urticaria Control After Symptom Recurrence in Chronic Inducible Urticaria
March 1, 2026
Top